Health
Phase 3 trials show AstraZeneca COVID vaccine has up to 90% efficacy – CIDRAP
The peer-reviewed data mirror unpublished results noted last month by the researchers, with up to 90% protection.
The first full peer-reviewed results of phase 3 trials of the COVID-19 vaccine developed by AstraZeneca and Oxford University show that it is safe and up to 90% effective in preventing infection, supporting regulatory submissions for emergency use.
The interim analysis, published today in The Lancet, identified no severe coronavirus disease or hospitalizations in pooled results from the 11,636 adults vaccinated in the United Kingdom and Brazil. Of the 11,636 adults, 131 (1.1%) had symptomatic COVID-19…
-
Noosa News13 hours agoMassive wind farm project in Queensland axed amid community backlash
-
Business17 hours agoIAG shares are racing higher today. Here’s why
-
Noosa News14 hours agoProp Allan Alaalatoa returns to the Wallabies line-up for Rugby Championship game against Argentina
-
General18 hours agoQueensland government dumps Forest Wind project